Movatterモバイル変換


[0]ホーム

URL:


GB2246514B - Sustained release pharmaceutical compositions and the preparation of particles for use therein - Google Patents

Sustained release pharmaceutical compositions and the preparation of particles for use therein

Info

Publication number
GB2246514B
GB2246514BGB9116472AGB9116472AGB2246514BGB 2246514 BGB2246514 BGB 2246514BGB 9116472 AGB9116472 AGB 9116472AGB 9116472 AGB9116472 AGB 9116472AGB 2246514 BGB2246514 BGB 2246514B
Authority
GB
United Kingdom
Prior art keywords
particles
preparation
pharmaceutical compositions
sustained release
release pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9116472A
Other versions
GB9116472D0 (en
GB2246514A (en
Inventor
Jean-Marc Ruiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016885Aexternal-prioritypatent/GB9016885D0/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SASfiledCriticalSociete de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to GB9116472ApriorityCriticalpatent/GB2246514B/en
Publication of GB9116472D0publicationCriticalpatent/GB9116472D0/en
Publication of GB2246514ApublicationCriticalpatent/GB2246514A/en
Application grantedgrantedCritical
Publication of GB2246514BpublicationCriticalpatent/GB2246514B/en
Anticipated expirationlegal-statusCritical
Expired - Fee Relatedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

GB9116472A1990-08-011991-07-31Sustained release pharmaceutical compositions and the preparation of particles for use thereinExpired - Fee RelatedGB2246514B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
GB9116472AGB2246514B (en)1990-08-011991-07-31Sustained release pharmaceutical compositions and the preparation of particles for use therein

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
GB909016885AGB9016885D0 (en)1990-08-011990-08-01Sustained release pharmaceutical compositions
GB9116472AGB2246514B (en)1990-08-011991-07-31Sustained release pharmaceutical compositions and the preparation of particles for use therein

Publications (3)

Publication NumberPublication Date
GB9116472D0 GB9116472D0 (en)1991-09-11
GB2246514A GB2246514A (en)1992-02-05
GB2246514Btrue GB2246514B (en)1993-12-15

Family

ID=26297422

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB9116472AExpired - Fee RelatedGB2246514B (en)1990-08-011991-07-31Sustained release pharmaceutical compositions and the preparation of particles for use therein

Country Status (1)

CountryLink
GB (1)GB2246514B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5843480A (en)1994-03-141998-12-01Euro-Celtique, S.A.Controlled release diamorphine formulation
US5849240A (en)1993-11-231998-12-15Euro-Celtique, S.A.Method of preparing sustained release pharmaceutical compositions
US5891471A (en)1993-11-231999-04-06Euro-Celtique, S.A.Pharmaceutical multiparticulates
US5958452A (en)1994-11-041999-09-28Euro-Celtique, S.A.Extruded orally administrable opioid formulations
US6068855A (en)1994-11-032000-05-30Euro-Celtique S. A.Pharmaceutical composition containing a fusible carrier and method for producing the same
US6254887B1 (en)1993-05-102001-07-03Euro-Celtique S.A.Controlled release tramadol
US6528093B1 (en)1992-12-072003-03-04Takeda Chemical Industries, Ltd.Sustained-release preparation
US8920842B2 (en)1999-11-152014-12-30Piramal Healthcare (Canada) Ltd.Temperature controlled and pH dependent self gelling biopolymeric aqueous solution

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CA2134464A1 (en)*1992-05-051993-11-11Stanley TockerMicroencapsulation
JP3277342B2 (en)*1992-09-022002-04-22武田薬品工業株式会社 Manufacturing method of sustained release microcapsules
GB9310030D0 (en)*1993-05-151993-06-30ScrasDry processed particles and process for the preparation of the same
HUT75469A (en)*1994-02-281997-05-28Medinova Med Consulting GmbhDrug targeting system, method for preparing same and its use
DE19500977C2 (en)*1995-01-141999-01-07Lohmann Therapie Syst Lts Solid drug form with active ingredient distributed in polymeric material
TW448055B (en)*1995-09-042001-08-01Takeda Chemical Industries LtdMethod of production of sustained-release preparation
FR2748205A1 (en)1996-05-061997-11-07Debio Rech Pharma Sa PHARMACEUTICAL COMPOSITIONS FOR THE CONTROLLED RELEASE OF INSOLUBLE ACTIVE SUBSTANCES
US6419961B1 (en)1996-08-292002-07-16Takeda Chemical Industries, Ltd.Sustained release microcapsules of a bioactive substance and a biodegradable polymer
US5858531A (en)*1996-10-241999-01-12Bio SyntechMethod for preparation of polymer microparticles free of organic solvent traces
FR2762318B1 (en)*1997-04-181999-09-17Pharma Biotech COMPOSITIONS HAVING SUSTAINED RELEASE AND A PROCESS FOR THEIR PREPARATION
FR2776516B1 (en)*1998-03-252001-05-25Pharma Biotech COMPOSITIONS HAVING SUSTAINED RELEASE AND THEIR PREPARATION METHOD
MY118835A (en)1997-04-182005-01-31Ipsen Pharma BiotechSustained release compositions and the process for their preparation
KR100289471B1 (en)*1998-01-192001-09-17김충섭A controlled/sustained implant delivery containing fentanyls
KR19990065921A (en)*1998-01-191999-08-16김충섭 Antimicrobial sustained-release drugs
DE19918325A1 (en)1999-04-222000-10-26Euro Celtique SaExtruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
FR2865938B1 (en)2004-02-052006-06-02Sod Conseils Rech Applic SOLID DELAY FORMULATION COMPRISING TRIPTORELINE ACETATE

Cited By (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6528093B1 (en)1992-12-072003-03-04Takeda Chemical Industries, Ltd.Sustained-release preparation
US6254887B1 (en)1993-05-102001-07-03Euro-Celtique S.A.Controlled release tramadol
US6326027B1 (en)1993-05-102001-12-04Euro-Celtique S.A.Controlled release formulation
US7074430B2 (en)1993-05-102006-07-11Euro-Celtique S.A.Controlled release tramadol tramadol formulation
US5965163A (en)1993-11-231999-10-12Euro-Celtique, S.A.Substained release compositions and a method of preparing pharmaceutical compositions
US5849240A (en)1993-11-231998-12-15Euro-Celtique, S.A.Method of preparing sustained release pharmaceutical compositions
US5891471A (en)1993-11-231999-04-06Euro-Celtique, S.A.Pharmaceutical multiparticulates
US6162467A (en)1993-11-232000-12-19Euro-Celtique, S.A.Sustained release compositions and a method of preparing pharmaceutical compositions
US5843480A (en)1994-03-141998-12-01Euro-Celtique, S.A.Controlled release diamorphine formulation
US6068855A (en)1994-11-032000-05-30Euro-Celtique S. A.Pharmaceutical composition containing a fusible carrier and method for producing the same
US5965161A (en)1994-11-041999-10-12Euro-Celtique, S.A.Extruded multi-particulates
US6335033B2 (en)1994-11-042002-01-01Euro-Celtique, S.A.Melt-extrusion multiparticulates
US6261599B1 (en)1994-11-042001-07-17Euro-Celtique, S.A.Melt-extruded orally administrable opioid formulations
US6706281B2 (en)1994-11-042004-03-16Euro-Celtique, S.A.Melt-extrusion multiparticulates
US5958452A (en)1994-11-041999-09-28Euro-Celtique, S.A.Extruded orally administrable opioid formulations
US8920842B2 (en)1999-11-152014-12-30Piramal Healthcare (Canada) Ltd.Temperature controlled and pH dependent self gelling biopolymeric aqueous solution

Also Published As

Publication numberPublication date
GB9116472D0 (en)1991-09-11
GB2246514A (en)1992-02-05

Similar Documents

PublicationPublication DateTitle
GB2246514B (en)Sustained release pharmaceutical compositions and the preparation of particles for use therein
IL102591A0 (en)Compositions for the sustained and controlled release of medicaments and their preparation
NZ238545A (en)Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof
ZA915565B (en)Preparation process of sustained release compositions and the compositions thus obtained
GB2230185B (en)Sustained release pharmaceutical compositions
AU8050791A (en)Compositions and methods for the controlled release of soluble active substances
IL107978A0 (en)Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL113123A (en)Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing them
IL97122A0 (en)Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
IL108073A0 (en)Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
NZ233011A (en)Thieno-triazole-diazepine and pharmaceutical compositions
ZA904925B (en)Sustained release pharmaceutical compositions
IL98477A0 (en)Resorption-improved pharmaceutical somatostatin compositions and their preparation
IL98934A0 (en)Stable pharmaceutical compositions and their preparation
HUT67287A (en)Piperazynil camphor derivatives and pharmaceutical compositions containing them
IL84104A0 (en)Sustained release pharmaceutical compositions and their preparation
ZA933426B (en)New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them
IL102116A (en)Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
NZ239483A (en)Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
IL117395A0 (en)Bicyclic compounds preparation thereof and use in pharmaceutical compositions
IL113415A0 (en)Dihydrodibenzoquinolinediones their preparation and use and pharmaceutical compositions containing them
HU896636D0 (en)Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
SG25394G (en)Sustained release pharmaceutical compositions and the preparation of particles for use therein.
IL93139A0 (en)Pharmaceutical compositions comprising suramin and methods for the use thereof
NZ240873A (en)6-cyclohexyl-2'-o-methyl-adenosine hydrate preparation and pharmaceutical compositions thereof

Legal Events

DateCodeTitleDescription
PCNPPatent ceased through non-payment of renewal fee

Effective date:20090731


[8]ページ先頭

©2009-2025 Movatter.jp